Literature DB >> 22091908

The sensitivity of adverse event cost estimates to diagnostic coding error.

Gavin Wardle1, Walter P Wodchis, Audrey Laporte, Geoffrey M Anderson, G Ross Baker.   

Abstract

OBJECTIVE: To examine the impact of diagnostic coding error on estimates of hospital costs attributable to adverse events. DATA SOURCES: Original and reabstracted medical records of 9,670 complex medical and surgical admissions at 11 hospital corporations in Ontario from 2002 to 2004. Patient specific costs, not including physician payments, were retrieved from the Ontario Case Costing Initiative database. STUDY
DESIGN: Adverse events were identified among the original and reabstracted records using ICD10-CA (Canadian adaptation of ICD10) codes flagged as postadmission complications. Propensity score matching and multivariate regression analysis were used to estimate the cost of the adverse events and to determine the sensitivity of cost estimates to diagnostic coding error. PRINCIPAL
FINDINGS: Estimates of the cost of the adverse events ranged from $16,008 (metabolic derangement) to $30,176 (upper gastrointestinal bleeding). Coding errors caused the total cost attributable to the adverse events to be underestimated by 16 percent. The impact of coding error on adverse event cost estimates was highly variable at the organizational level.
CONCLUSIONS: Estimates of adverse event costs are highly sensitive to coding error. Adverse event costs may be significantly underestimated if the likelihood of error is ignored. © Health Research and Educational Trust.

Entities:  

Mesh:

Year:  2011        PMID: 22091908      PMCID: PMC3423172          DOI: 10.1111/j.1475-6773.2011.01340.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  29 in total

Review 1.  Administrative data based patient safety research: a critical review.

Authors:  C Zhan; M R Miller
Journal:  Qual Saf Health Care       Date:  2003-12

2.  Coding response to a case-mix measurement system based on multiple diagnoses.

Authors:  Colin Preyra
Journal:  Health Serv Res       Date:  2004-08       Impact factor: 3.402

3.  Medicare payment for selected adverse events: building the business case for investing in patient safety.

Authors:  Chunliu Zhan; Bernard Friedman; Andrew Mosso; Peter Pronovost
Journal:  Health Aff (Millwood)       Date:  2006 Sep-Oct       Impact factor: 6.301

4.  Tracking rates of Patient Safety Indicators over time: lessons from the Veterans Administration.

Authors:  Amy K Rosen; Shibei Zhao; Peter Rivard; Susan Loveland; Maria E Montez-Rath; Anne Elixhauser; Patrick S Romano
Journal:  Med Care       Date:  2006-09       Impact factor: 2.983

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Identifying complications of care using administrative data.

Authors:  L I Iezzoni; J Daley; T Heeren; S M Foley; E S Fisher; C Duncan; J S Hughes; G A Coffman
Journal:  Med Care       Date:  1994-07       Impact factor: 2.983

7.  Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.

Authors:  D C Classen; S L Pestotnik; R S Evans; J F Lloyd; J P Burke
Journal:  JAMA       Date:  1997 Jan 22-29       Impact factor: 56.272

8.  The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group.

Authors:  D W Bates; N Spell; D J Cullen; E Burdick; N Laird; L A Petersen; S D Small; B J Sweitzer; L L Leape
Journal:  JAMA       Date:  1997 Jan 22-29       Impact factor: 56.272

9.  Nurse staffing in hospitals: is there a business case for quality?

Authors:  Jack Needleman; Peter I Buerhaus; Maureen Stewart; Katya Zelevinsky; Soeren Mattke
Journal:  Health Aff (Millwood)       Date:  2006 Jan-Feb       Impact factor: 6.301

10.  Comparison of three methods for estimating rates of adverse events and rates of preventable adverse events in acute care hospitals.

Authors:  Philippe Michel; Jean Luc Quenon; Anne Marie de Sarasqueta; Olivier Scemama
Journal:  BMJ       Date:  2004-01-24
View more
  6 in total

1.  A New Strategy to Evaluate Technical Efficiency in Hospitals Using Homogeneous Groups of Casemix : How to Evaluate When There is Not DRGs?

Authors:  Manuel Villalobos-Cid; Max Chacón; Pedro Zitko; Mario Instroza-Ponta
Journal:  J Med Syst       Date:  2016-02-15       Impact factor: 4.460

2.  The impact of hospital harm on length of stay, costs of care and length of person-centred episodes of care: a retrospective cohort study.

Authors:  Lauren Tessier; Sara J T Guilcher; Yu Qing Bai; Ryan Ng; Walter P Wodchis
Journal:  CMAJ       Date:  2019-08-12       Impact factor: 8.262

3.  Diagnostic Coding Intensity among a Pneumonia Inpatient Cohort Using a Risk-Adjustment Model and Claims Data: A U.S. Population-Based Study.

Authors:  Ruchi Mishra; Himadri Verma; Venkata Bhargavi Aynala; Paul R Arredondo; John Martin; Michael Korvink; Laura H Gunn
Journal:  Diagnostics (Basel)       Date:  2022-06-19

4.  Healthy Life-Years Lost and Excess Bed-Days Due to 6 Patient Safety Incidents: Empirical Evidence From English Hospitals.

Authors:  Katharina D Hauck; Shaolin Wang; Charles Vincent; Peter C Smith
Journal:  Med Care       Date:  2017-02       Impact factor: 2.983

5.  Spinal Cord Injury Clinical Registries: Improving Care across the SCI Care Continuum by Identifying Knowledge Gaps.

Authors:  Marcel F Dvorak; Christiana L Cheng; Nader Fallah; Argelio Santos; Derek Atkins; Suzanne Humphreys; Carly S Rivers; Barry A B White; Chester Ho; Henry Ahn; Brian K Kwon; Sean Christie; Vanessa K Noonan
Journal:  J Neurotrauma       Date:  2017-07-26       Impact factor: 5.269

6.  A Systematic Review of Methods for Medical Record Analysis to Detect Adverse Events in Hospitalized Patients.

Authors:  Dorthe O Klein; Roger J M W Rennenberg; Richard P Koopmans; Martin H Prins
Journal:  J Patient Saf       Date:  2021-12-01       Impact factor: 2.243

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.